High-level production of recombinant immunoglobulins in mammalian cells
- 31 October 1993
- journal article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 4 (5) , 573-576
- https://doi.org/10.1016/0958-1669(93)90079-c
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- “Primatization” of Recombinant Antibodies for Immunotherapy of Human Diseases: A Macaque/Human Chimeric Antibody Against Human CD4Nature Biotechnology, 1992
- High Level Expression of a Chimeric Anti–Ganglioside GD2 Antibody: Genomic Kappa Sequences Improve Expression in COS and CHO CellsNature Biotechnology, 1992
- A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognitionCell, 1992
- Effect of cloned gene dosage on cell growth and hepatitis B surface antigen synthesis and secretion in recombinant CHO cellsBiotechnology & Bioengineering, 1992
- High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable MarkerNature Biotechnology, 1992
- Protein Engineering of AntibodiesCritical Reviews in Biotechnology, 1992
- Vaccinia Virus: A Tool for Research and Vaccine DevelopmentScience, 1991
- High-level expression of chimeric antibodies using adapted cDNA variable region cassettesJournal of Immunological Methods, 1989
- High Expression in Mammalian Cells Without AmplificationNature Biotechnology, 1989
- Expression of an immunoglobulin kappa light-chain gene in lymphoid cells using a bovine papilloma-virus-1 (BPV-1) vectorGene, 1988